|
[1]
|
Shi, Z., Taylor, A.W., Riley, M., et al. (2018) Association between Dietary Patterns, Cadmium Intake and Chronic Kidney Disease among Adults. Clinical Nutrition, 37, 276-284. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
(2020) Global, Regional, and National Burden of Chronic Kidney Disease, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 395, 709-733. [Google Scholar] [CrossRef]
|
|
[3]
|
Matsushita, K., Van Der Velde, M., Astor, B.C., et al. (2010) Association of Estimated Glomerular Filtration Rate and Albuminuria with All-Cause and Cardiovascular Mortality in General Population Cohorts: A Collaborative Meta-Analysis. The Lancet, 375, 2073-2081. [Google Scholar] [CrossRef]
|
|
[4]
|
Astor, B.C., Matsushita, K., Gansevoort, R.T., et al. (2011) Lower Estimated Glomerular Filtration Rate and Higher Albuminuria Are Associated with Mortality and End-Stage Renal Disease. A Collaborative Meta-Analysis of Kidney Disease Population Cohorts. Kidney International, 79, 1331-1340. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Zelle, D.M., Klaassen, G., Van Adrichem, E., et al. (2017) Physical Inactivity: A Risk Factor and Target for Intervention in Renal Care. Nature Reviews Nephrology, 13, 152-168. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Xia, J., Wang, L., Ma, Z., et al. (2017) Cigarette Smoking and Chronic Kidney Disease in the General Population: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Nephrology Dialysis Transplantation, 32, 475-487. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
White, S.L., Polkinghorne, K.R., Cass, A., et al. (2009) Alcohol Consumption and 5-Year Onset of Chronic Kidney Disease: The AusDiab Study. Nephrology Dialysis Transplantation, 24, 2464-2472. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Cosola, C., Sabatino, A., Di Bari, I., et al. (2018) Nutrients, Nutraceuticals, and Xenobiotics Affecting Renal Health. Nutrients, 10, Article No. 808. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Biruete, A., Chen, N.X., Metzger, C.E., et al. (2023) The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) in a Rat Model of CKD. JBMR plus, 7, E10837. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Ariyanopparut, S., Metta, K., Avihingsanon, Y., et al. (2023) The Role of a Low Protein Diet Supplemented with Ketoanalogues on Kidney Progression in Pre-Dialysis Chronic Kidney Disease Patients. Scientific Reports, 13, Article No. 15459. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Cecchi, S., Di Stante, S., Belcastro, S., et al. (2023) Supplemented Very Low Protein Diet (SVLPD) in Patients with Advanced Chronic Renal Failure: Clinical and Economic Benefits. Nutrients, 15, Article No. 3568. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Cirillo, M., Cavallo, P., Palladino, R., et al. (2022) Relationship of the Intake of Water and Other Beverages with Renal Endpoints: Cross-Sectional and Longitudinal Data-Observational, Population-Based Study. Journal of Renal Nutrition, 32, 68-77. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Wang, W., Le, T., Wang, W., et al. (2023) Effects of Key Components on the Antioxidant Activity of Black Tea. Foods, 12, Article No. 3134. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Niu, J., Shang, M., Li, X., et al. (2023) Health Benefits, Mechanisms of Interaction with Food Components, and Delivery of Tea Polyphenols: A Review. Critical Reviews in Food Science and Nutrition. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Wei, Y., Pang, Y., Ma, P., et al. (2023) Green Preparation, Safety Control and Intelligent Processing of High-Quality Tea Extract. Critical Reviews in Food Science and Nutrition. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Kanwar, J., Taskeen, M., Mohammad, I., et al. (2012) Recent Advances on Tea Polyphenols. Frontiers in Bioscience (Elite Ed), 4, 111-131. [Google Scholar] [CrossRef]
|
|
[17]
|
Khokhar, S. and Magnusdottir, S.G. (2002) Total Phenol, Catechin, and Caffeine Contents of Teas Commonly Consumed in the United Kingdom. Journal of Agricultural and Food Chemistry, 50, 565-570. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Higdon, J.V. and Frei, B. (2003) Tea Catechins and Polyphenols: Health Effects, Metabolism, and Antioxidant Functions. Critical Reviews in Food Science and Nutrition, 43, 89-143. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Daenen, K., Andries, A., Mekahli, D., et al. (2019) Oxidative Stress in Chronic Kidney Disease. Pediatric Nephrology, 34, 975-991. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Peluso, I. and Serafini, M. (2017) Antioxidants from Black and Green Tea: From Dietary Modulation of Oxidative Stress to Pharmacological Mechanisms. British Journal of Pharmacology, 174, 1195-1208. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Tang, G.Y., Meng, X., Gan, R.Y., et al. (2019) Health Functions and Related Molecular Mechanisms of Tea Components: An Update Review. International Journal of Molecular Sciences, 20, Article No. 6196. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Mihai, S., Codrici, E., Popescu, I.D., et al. (2018) Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome. Journal of Immunology Research, 2018, Article ID: 2180373. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Cornelis, M.C. and Van Dam, R.M. (2020) Habitual Coffee and Tea Consumption and Cardiometabolic Biomarkers in the UK Biobank: The Role of Beverage Types and Genetic Variation. The Journal of Nutrition, 150, 2772-2788. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Wahl, P., Ducasa, G.M. and Fornoni, A. (2016) Systemic and Renal Lipids in Kidney Disease Development and Progression. American Journal of Physiology-Renal Physiology, 310, F433-F445. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Tofovic, S.P., Kost, C.J., Jackson, E.K., et al. (2002) Long-Term Caffeine Consumption Exacerbates Renal Failure in Obese, Diabetic, ZSF1 (Fa-Fa(Cp)) Rats. Kidney International, 61, 1433-1444. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Livingston, M.J., Shu, S., Fan, Y., et al. (2023) Tubular Cells Produce FGF2 via Autophagy after Acute Kidney Injury Leading to Fibroblast Activation and Renal Fibrosis. Autophagy, 19, 256-277. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Jiang, M., Bai, M., Lei, J., et al. (2020) Mitochondrial Dysfunction and the AKI-to-CKD Transition. American Journal of Physiology-Renal Physiology, 319, F1105-F1116. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Kirita, Y., Wu, H., Uchimura, K., et al. (2020) Cell Profiling of Mouse Acute Kidney Injury Reveals Conserved Cellular Responses to Injury. Proceedings of the National Academy of Sciences of the United States of America, 117, 15874-15883. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Nagata, K., Horino, T., Hatakeyama, Y., et al. (2021) Effects of Transient Acute Kidney Injury, Persistent Acute Kidney Injury and Acute Kidney Disease on the Long-Term Renal Prognosis after an Initial Acute Kidney Injury Event. Nephrology (Carlton), 26, 312-318. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Wang, Y., Wang, B., Du, F., et al. (2015) Epigallocatechin-3-Gallate Attenuates Unilateral Ureteral Obstruction-Induced Renal Interstitial Fibrosis in Mice. Journal of Histochemistry & Cytochemistry, 63, 270-279. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Wang, Y., Wang, B., Du, F., et al. (2015) Epigallocatechin-3-Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF-KappaB and Nrf2/HO-1 Signalling Pathway Regulation. Basic & Clinical Pharmacology & Toxicology, 117, 164-172. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Wang, Y., Liu, N., Su, X., et al. (2015) Epigallocatechin-3-Gallate Attenuates Transforming Growth Factor-Beta1 Induced Epithelial-Mesenchymal Transition via Nrf2 Regulation in Renal Tubular Epithelial Cells. Biomedicine & Pharmacotherapy, 70, 260-267. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Reggiani, F., L’Imperio, V., Calatroni, M., et al. (2023) Goodpasture Syndrome and Anti-Glomerular Basement Membrane Disease. Clinical and Experimental Rheumatology, 41, 964-974. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Kronbichler, A., Bajema, I., Geetha, D., et al. (2023) Novel Aspects in the Pathophysiology and Diagnosis of Glomerular Diseases. Annals of the Rheumatic Diseases, 82, 585-593. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Caillard, P., Vigneau, C., Halimi, J.M., et al. (2023) Prognostic Value of Complement Serum C3 Level and Glomerular C3 Deposits in Anti-Glomerular Basement Membrane Disease. Frontiers in Immunology, 14, Article ID: 1190394. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Sanders, J.S., Rutgers, A., Stegeman, C.A., et al. (2011) Pulmonary: Renal Syndrome with a Focus on Anti-GBM Disease. Seminars in Respiratory and Critical Care Medicine, 32, 328-334. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Peng, A., Ye, T., Rakheja, D., et al. (2011) The Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate Ameliorates Experimental Immune-Mediated Glomerulonephritis. Kidney International, 80, 601-611. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Low, G., Huang, G., Fu, W., et al. (2016) Review of Renal Cell Carcinoma and Its Common Subtypes in Radiology. World Journal of Radiology, 8, 484-500. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Ye, T., Zhen, J., Du, Y., et al. (2015) Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate Restores Nrf2 Activity and Ameliorates Crescentic Glomerulonephritis. PLOS ONE, 10, E119543. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Liu, M., Zhang, Y., Ye, Z., et al. (2023) Association of Unsweetened and Sweetened Tea Consumption with the Risk of New-Onset Chronic Kidney Disease: Findings from UK Biobank and Coronary Artery Risk Development in Young Adults (CARDIA) Study. Journal of Global Health, 13, Article No. 4094. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Zhang, Y., Xiong, Y., Shen, S., et al. (2022) Causal Association between Tea Consumption and Kidney Function: A Mendelian Randomization Study. Frontiers in Nutrition, 9, Article ID: 801591. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Herber-Gast, G.C., Van Essen, H., Verschuren, W.M., et al. (2016) Coffee and Tea Consumption in Relation to Estimated Glomerular Filtration Rate: Results from the Population-Based Longitudinal Doetinchem Cohort Study. The American Journal of Clinical Nutrition, 103, 1370-1377. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Diaz-Lopez, A., Paz-Graniel, I., Ruiz, V., et al. (2021) Consumption of Caffeinated Beverages and Kidney Function Decline in an Elderly Mediterranean Population with Metabolic Syndrome. Scientific Reports, 11, Article No. 8719. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Van, Hasselt, T.J., Pickles, O., Midgley-Hunt, A., et al. (2014) Effects of Tea Consumption on Renal Function in a Metropolitan Chinese Population: The Guangzhou Biobank Cohort Study. Journal of Renal Nutrition, 24, 26-31. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Juan, Y.S., Chuang, S.M., Long, C.Y., et al. (2012) Protein Kinase C Inhibitor Prevents Renal Apoptotic and Fibrotic Changes in Response to Partial Ureteric Obstruction. BJU International, 110, 283-292. [Google Scholar] [CrossRef]
|
|
[46]
|
Ojima, A., Ishibashi, Y., Matsui, T., et al. (2013) Glucagon-Like Peptide-1 Receptor Agonist Inhibits Asymmetric Dimethylarginine Generation in the Kidney of Streptozotocin-Induced Diabetic Rats by Blocking Advanced Glycation End Product-Induced Protein Arginine Methyltranferase-1 Expression. The American Journal of Pathology, 182, 132-141. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Yamabe, N., Yokozawa, T., Oya, T., et al. (2006) Therapeutic Potential of (−)-Epigallocatechin 3-O-Gallate on Renal Damage in Diabetic Nephropathy Model Rats. Journal of Pharmacology and Experimental Therapeutics, 319, 228-236. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Yoon, S.P., Maeng, Y.H., Hong, R., et al. (2014) Protective Effects of Epigallocatechin Gallate (EGCG) on Streptozotocin-Induced Diabetic Nephropathy in Mice. Acta Histochem, 116, 1210-1215. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Mineharu, Y., Koizumi, A., Wada, Y., et al. (2011) Coffee, Green Tea, Black Tea and Oolong Tea Consumption and Risk of Mortality from Cardiovascular Disease in Japanese Men and Women. Journal of Epidemiology and Community Health, 65, 230-240. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Asbaghi, O., Fouladvand, F., Gonzalez, M.J., et al. (2019) The Effect of Green Tea on C-Reactive Protein and Biomarkers of Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Complementary Therapies in Medicine, 46, 210-216. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Maron, D.J., Lu, G.P., Cai, N.S., et al. (2003) Cholesterol-Lowering Effect of a Theaflavin-Enriched Green Tea Extract: A Randomized Controlled Trial. Archives of Internal Medicine, 163, 1448-1453. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Nagao, T., Hase, T. and Tokimitsu, I. (2007) A Green Tea Extract High in Catechins Reduces Body Fat and Cardiovascular Risks in Humans. Obesity (Silver Spring), 15, 1473-1483. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Long, A.N. and Dagogo-Jack, S. (2011) Comorbidities of Diabetes and Hypertension: Mechanisms and Approach to Target Organ Protection. The Journal of Clinical Hypertension (Greenwich), 13, 244-251. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Maggiore, U., Budde, K., Heemann, U., et al. (2017) Long-Term Risks of Kidney Living Donation: Review and Position Paper by the ERA-EDTA DESCARTES Working Group. Nephrology Dialysis Transplantation, 32, 216-223. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Van Den Born, J.C., Hammes, H.P., Greffrath, W., et al. (2016) Gasotransmitters in Vascular Complications of Diabetes. Diabetes, 65, 331-345. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Alicic, R.Z., Rooney, M.T. and Tuttle, K.R. (2017) Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clinical Journal of the American Society of Nephrology, 12, 2032-2045. [Google Scholar] [CrossRef]
|
|
[57]
|
Mohan, T., Narasimhan, K., Ravi, D.B., et al. (2020) Role of Nrf2 Dysfunction in the Pathogenesis of Diabetic Nephropathy: Therapeutic Prospect of Epigallocatechin-3-Gallate. Free Radical Biology and Medicine, 160, 227-238. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Nie, J., Yu, C., Guo, Y., et al. (2021) Tea Consumption and Long-Term Risk of Type 2 Diabetes and Diabetic Complications: A Cohort Study of 0.5 Million Chinese Adults. The American Journal of Clinical Nutrition, 114, 194-202. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Kao, Y.H., Chang, H.H., Lee, M.J., et al. (2006) Tea, Obesity, and Diabetes. Molecular Nutrition & Food Research, 50, 188-210. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Stote, K.S. and Baer, D.J. (2008) Tea Consumption May Improve Biomarkers of Insulin Sensitivity and Risk Factors for Diabetes. The Journal of Nutrition, 138, 1584S-1588S. [Google Scholar] [CrossRef]
|
|
[61]
|
Shimizu, M., Kobayashi, Y., Suzuki, M., et al. (2000) Regulation of Intestinal Glucose Transport by Tea Catechins. Biofactors, 13, 61-65. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Kobayashi, Y., Suzuki, M., Satsu, H., et al. (2000) Green Tea Polyphenols Inhibit the Sodium-Dependent Glucose Transporter of Intestinal Epithelial Cells by a Competitive Mechanism. Journal of Agricultural and Food Chemistry, 48, 5618-5623. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Kao, Y.H., Hiipakka, R.A. and Liao, S. (2000) Modulation of Endocrine Systems and Food Intake by Green Tea Epigallocatechin Gallate. Endocrinology, 141, 980-987. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Waltner-Law, M.E., Wang, X.L., Law, B.K., et al. (2002) Epigallocatechin Gallate, a Constituent of Green Tea, Represses Hepatic Glucose Production. Journal of Biological Chemistry, 277, 34933-34940. [Google Scholar] [CrossRef]
|
|
[65]
|
Anderson, R.A. and Polansky, M.M. (2002) Tea Enhances Insulin Activity. Journal of Agricultural and Food Chemistry, 50, 7182-7186. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Yang, T.T. and Koo, M.W. (2000) Inhibitory Effect of Chinese Green Tea on Endothelial Cell-Induced LDL Oxidation. Atherosclerosis, 148, 67-73. [Google Scholar] [CrossRef]
|
|
[67]
|
Zheng, X.X., Xu, Y.L., Li, S.H., et al. (2013) Effects of Green Tea Catechins with or without Caffeine on Glycemic Control in Adults: A Meta-Analysis of Randomized Controlled Trials. The American Journal of Clinical Nutrition, 97, 750-762. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Liu, K., Zhou, R., Wang, B., et al. (2013) Effect of Green Tea on Glucose Control and Insulin Sensitivity: A Meta-Analysis of 17 Randomized Controlled Trials. The American Journal of Clinical Nutrition, 98, 340-348. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Yi, Q.Y., Qi, J., Yu, X.J., et al. (2016) Paraventricular Nucleus Infusion of Epigallocatechin-3-O-Gallate Improves Renovascular Hypertension. Cardiovascular Toxicology, 16, 276-285. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Yi, Q.Y., Li, H.B., Qi, J., et al. (2016) Chronic Infusion of Epigallocatechin-3-O-Gallate into the Hypothalamic Paraventricular Nucleus Attenuates Hypertension and Sympathoexcitation by Restoring Neurotransmitters and Cytokines. Toxicology Letters, 262, 105-113. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Kanlaya, R. and Thongboonkerd, V. (2019) Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases. Advances in Nutrition, 10, 112-121. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Thangapandiyan, S. and Miltonprabu, S. (2014) Epigallocatechin Gallate Supplementation Protects against Renal Injury Induced by Fluoride Intoxication in Rats: Role of Nrf2/HO-1 Signaling. Toxicology Reports, 1, 12-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Sahin, K., Tuzcu, M., Gencoglu, H., et al. (2010) Epigallocatechin-3-Gallate Activates Nrf2/HO-1 Signaling Pathway in Cisplatin-Induced Nephrotoxicity in Rats. Life Sciences, 87, 240-245. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Zhou, P., Yu, J.F., Zhao, C.G., et al. (2013) Therapeutic Potential of EGCG on Acute Renal Damage in a Rat Model of Obstructive Nephropathy. Molecular Medicine Reports, 7, 1096-1102. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Luo, D., Xu, J., Chen, X., et al. (2020) (−)-Epigallocatechin-3-Gallate (EGCG) Attenuates Salt-Induced Hypertension and Renal Injury in Dahl Salt-Sensitive Rats. Scientific Reports, 10, Article No. 4783. [Google Scholar] [CrossRef] [PubMed]
|
|
[76]
|
Johnson, R.J., Bakris, G.L., Borghi, C., et al. (2018) Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation. American Journal of Kidney Diseases, 71, 851-865. [Google Scholar] [CrossRef] [PubMed]
|
|
[77]
|
Chen, G., Tan, M.L., Li, K.K., et al. (2015) Green Tea Polyphenols Decreases Uric Acid Level through Xanthine Oxidase and Renal Urate Transporters in Hyperuricemic Mice. Journal of Ethnopharmacology, 175, 14-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[78]
|
Andres-Hernando, A., Orlicky, D.J., Cicerchi, C., et al. (2023) High Fructose Corn Syrup Accelerates Kidney Disease and Mortality in Obese Mice with Metabolic Syndrome. Biomolecules, 13, Article No. 780. [Google Scholar] [CrossRef] [PubMed]
|
|
[79]
|
Choudhary, A.K. and Pretorius, E. (2017) Revisiting the Safety of Aspartame. Nutrition Reviews, 75, 718-730. [Google Scholar] [CrossRef] [PubMed]
|